| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥17.4B | ¥22.2B | -21.7% |
| Operating Income | ¥-1.7B | ¥-0.7B | -131.1% |
| Ordinary Income | ¥-2.0B | ¥-1.0B | -103.0% |
| Net Income | ¥-2.0B | ¥-1.4B | -48.5% |
| ROE | -166.8% | -43.0% | - |
FY2026 Q3 cumulative results: Revenue 17.4B yen (YoY -21.7%), Operating Loss 1.7B yen (YoY -131.1% deterioration), Ordinary Loss 2.0B yen (YoY -103.0% deterioration), Net Loss 2.0B yen (YoY -48.5% deterioration). The company experienced significant revenue contraction across both segments alongside deepening operating losses. Total assets declined to 26.2B yen from 31.4B yen, while equity decreased from 3.2B yen to 1.2B yen, indicating substantial capital erosion. Gross profit margin remained elevated at 58.5%, but selling, general and administrative expenses of 11.9B yen exceeded gross profit of 10.2B yen, driving the operating loss. Financial leverage increased to 21.52x as equity base weakened, amplifying negative ROE to -166.4%. Short-term debt stood at 8.51B yen against cash deposits of 12.06B yen, presenting refinancing considerations given the 60.9% short-term liability ratio.
Revenue declined 21.7% YoY to 17.4B yen, driven by contractions in both operating segments. The Wellness (Osteopathic Solution) segment generated revenue of 1,286M yen (down from 1,474M yen prior year), while the Financial Services segment contributed 454M yen (down from 749M yen prior year). Within Wellness, health support services declined significantly from 504M yen to 297M yen, a 41% reduction representing the largest absolute decline. Software and equipment/consumables remained relatively stable with minor declines. The Financial Services segment experienced a dramatic contraction in IFA (Independent Financial Advisor) business from 311M yen to 58M yen, explained by the divestiture of FP Design Co. stock completed in August 2025 following intra-group reorganization, limiting IFA operations to April-July 2025 only. Insurance agency services remained stable at 350M yen.
Operating loss expanded from 0.7B yen to 1.7B yen despite maintaining a 58.5% gross margin, as SG&A expenses remained elevated at 11.9B yen against declining revenue. The SG&A burden increased to 68.4% of revenue from 53.6% in the prior period, indicating insufficient cost adjustment to revenue reduction. Non-operating expenses netted approximately 0.3B yen, expanding ordinary loss to 2.0B yen. A special gain of 60M yen partially offset the pre-tax loss to 1.45B yen, but net loss reached 2.03B yen after tax effects. This represents a revenue down/profit down pattern with structural cost rigidity preventing loss containment despite high gross profitability.
The Wellness segment recorded revenue of 1,286M yen and operating loss of 84M yen, compared to prior year revenue of 1,474M yen and operating profit of 42M yen, representing a swing from profitability to loss. This segment constitutes the core business at 73.9% of total revenue. The Financial Services segment generated revenue of 454M yen with operating loss of 88M yen, compared to prior year revenue of 749M yen and operating loss of 117M yen. While the Financial Services segment reduced its loss in absolute terms, this occurred alongside substantial revenue contraction driven by the IFA business divestiture. The Wellness segment loss margin was -6.5%, while Financial Services loss margin was -19.4%, indicating both segments operated unprofitably but with Financial Services showing materially weaker profitability characteristics. The absence of positive operating income in either segment during Q3 cumulative period underscores the company-wide challenge in achieving operating leverage despite differentiated gross margin profiles across services.
[Profitability] ROE of -166.4% represents severe deterioration driven by net loss against eroded equity base of 1.2B yen; operating margin of -9.8% compares unfavorably to prior period's -3.2%, reflecting insufficient cost management; net profit margin of -11.7% versus prior -6.4% shows bottom-line deterioration; gross profit margin maintained at 58.5% indicates pricing power and service value retention. [Cash Quality] Cash and deposits of 12.06B yen provide 1.42x coverage of short-term debt of 8.51B yen; working capital of 3.79B yen yields current ratio of 119.7% and quick ratio of 109.8%, suggesting adequate near-term liquidity despite loss generation. [Investment Efficiency] Total asset turnover of 0.663 reflects declining revenue against asset base; inventory turnover of 96 days exceeds efficient norms, suggesting potential inventory optimization needs; receivables turnover of 69 days indicates collection cycle moderately aligned with business model. [Financial Health] Equity ratio of 4.7% (down from 10.2% prior year) signals critically thin capital buffer; debt-to-equity ratio of 20.51 represents extreme leverage concentration; interest coverage of -7.67x reflects negative operating income relative to interest expense of 22M yen, indicating challenged debt servicing capacity; goodwill of 94M yen represents 76.9% of equity, presenting material impairment risk if business recovery stalls.
Cash and deposits increased 0.34B yen YoY to 12.06B yen despite cumulative net losses, with this accumulation primarily attributable to working capital management and financing activities offsetting operational cash consumption. Accounts payable increased 0.32B yen (489.6% YoY), suggesting extended payment terms or intensified supplier credit utilization to preserve cash. Inventory decreased 0.69B yen and receivables declined 0.71B yen, collectively releasing approximately 1.4B yen in working capital as sales contracted. Long-term debt decreased 2.05B yen, indicating scheduled repayments or refinancing into short-term facilities, while short-term borrowings increased 0.95B yen, shifting maturity profile toward near-term obligations. The cash buildup alongside operational losses suggests financing inflows and working capital releases exceeded operating cash outflows and debt repayments. Short-term debt coverage by cash stands at 1.42x, providing buffer for near-term maturities but warranting close monitoring given 60.9% short-term liability ratio. The increase in payables turnover alongside inventory and receivables reduction indicates active working capital management to maintain liquidity during the loss period, though sustainability depends on supplier relationship maintenance and revenue stabilization.
Ordinary loss of 2.0B yen versus operating loss of 1.7B yen reflects net non-operating expense of approximately 0.3B yen, comprising primarily interest expense of 22M yen and other non-operating costs. Non-operating expenses represent 1.7% of revenue, a contained but meaningful drag given the operating loss position. Interest burden of 22M yen against negative operating income yields interest coverage of -7.67x, indicating reliance on financing activities or asset sales rather than operational cash generation for interest servicing. Pre-tax loss of 1.45B yen improved to net loss of 2.03B yen after tax effects, with the divergence suggesting limited tax benefit recognition on losses or deferred tax adjustments. Special gains of 60M yen provided one-time benefit, likely related to the FP Design divestiture referenced in segment notes, constituting non-recurring income. Absent cash flow statement data for the quarter, operating CF to net income ratio cannot be directly assessed; however, the combination of net losses with cash accumulation suggests working capital releases and financing activities supported liquidity. Core earnings quality remains challenged by ongoing operational losses and reliance on non-recurring items and working capital management rather than sustainable operating cash generation. The gross margin of 58.5% indicates underlying business model profitability potential, but realization requires SG&A rationalization to convert gross profit into operating income.
Full-year guidance projects revenue of 24.5B yen (YoY -14.7%) and operating loss of 1.41B yen. Against Q3 cumulative revenue of 17.4B yen, the company has achieved 71.0% of full-year revenue guidance, which is 21 percentage points behind the standard 92% expected progress through Q3 (assuming Q4 represents 8% in typical seasonal patterns). Operating loss of 1.71B yen cumulative through Q3 already exceeds the full-year guidance loss of 1.41B yen by 0.30B yen, indicating either anticipated Q4 operating profit or need for guidance revision. The deviation suggests Q4 revenue of 7.1B yen would be required to meet full-year target, representing 40.8% of annual revenue in a single quarter - an unusually high concentration inconsistent with Q1-Q3 run rates averaging 5.8B yen per quarter. Net loss guidance of 1.86B yen compares to Q3 cumulative net loss of 2.03B yen, implying Q4 net income of 0.17B yen to meet guidance - a significant reversal from Q1-Q3 loss trajectory. These progress rates and implied Q4 assumptions suggest elevated execution risk to achieving full-year guidance without material operating improvements or further guidance revision.
Annual dividend per share is forecasted at 0 yen for both interim and year-end, maintaining a no-dividend policy consistent with the loss-making position. With forecasted net loss of 1.86B yen for the full year, payout ratio is not applicable. The absence of dividend distributions reflects appropriate capital allocation prioritization toward financial stability and operational recovery over shareholder distributions given the negative earnings and thin equity base of 1.2B yen. No share buyback activity is disclosed in the available data. Total return ratio is therefore 0%, as both dividends and buybacks are absent. The dividend policy aligns with financial constraints and represents prudent cash preservation given the 4.7% equity ratio and 20.51 debt-to-equity ratio requiring capital rebuilding.
Revenue contraction risk: YoY revenue decline of 21.7% driven by both segment underperformance and strategic divestiture of IFA business, with visibility on stabilization unclear. Wellness segment health support revenue declined 41% YoY to 297M yen, representing structural demand weakness requiring recovery strategy execution.
Financial leverage and capital adequacy risk: Debt-to-equity ratio of 20.51 and equity ratio of 4.7% indicate critically thin capital buffer amplifying solvency risk. Negative interest coverage of -7.67x and cumulative deficit in retained earnings of 8.92B yen constrain financial flexibility and elevate refinancing risk.
Refinancing and liquidity risk: Short-term debt of 8.51B yen comprises 60.9% of total liabilities, with 1.42x cash coverage providing limited buffer. Maturity concentration requires successful refinancing or asset conversion to avoid liquidity stress, particularly given ongoing operating losses consuming cash.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of -9.8% substantially underperforms the IT/Telecom industry median of 8.0% (2025-Q3, n=103), placing the company in the lower quartile. Net profit margin of -11.7% compares unfavorably to industry median of 5.8% (IQR: 2.2%-12.0%), indicating earnings quality challenges. ROE of -166.4% reflects severe deviation from industry median of 8.2% (IQR: 3.5%-13.1%), driven by both operational losses and extreme financial leverage.
Financial Health: Equity ratio of 4.7% significantly trails industry median of 59.0% (IQR: 42.0%-71.7%), positioning the company in the bottom percentile for capital strength. Financial leverage of 21.52x far exceeds industry median of 1.66x (IQR: 1.37-2.34), indicating outlier leverage concentration. Current ratio of 119.7% falls below industry median of 2.13x (IQR: 1.56x-3.56x), though remains above 1.0x threshold.
Efficiency: Asset turnover of 0.663 approximates industry median of 0.68 (IQR: 0.49-0.94), suggesting asset utilization aligned with sector norms despite operational challenges. Inventory turnover of 96 days compares to industry median of 17 days (IQR: 4-48), indicating elevated inventory holding periods warranting optimization. Revenue growth of -21.7% sharply underperforms industry median growth of 10.4% (IQR: -1.3%-19.7%), placing the company in significant contraction versus sector expansion trend.
(Industry: IT/Telecom sector, 2025-Q3 period, n=93-103 companies depending on metric, Source: Proprietary analysis)
Gross margin resilience at 58.5% demonstrates underlying service value proposition and pricing power retention despite revenue pressures, suggesting potential for profit recovery if cost structure can be rationalized. However, SG&A expenses at 68.4% of revenue indicate structural cost rigidity requiring operational restructuring to achieve breakeven, with Q3 results showing insufficient cost adjustment velocity relative to 21.7% revenue decline.
Capital structure represents critical constraint with 4.7% equity ratio and 20.51 debt-to-equity ratio positioning the company at extreme financial leverage. Combined with negative interest coverage of -7.67x and 60.9% short-term liability ratio, near-term priorities center on capital restoration through potential equity raises or asset monetization, alongside securing favorable refinancing terms for 8.51B yen short-term debt. The 76.9% goodwill-to-equity ratio presents additional downside risk if impairment testing necessitates writedowns under continued operational losses.
Full-year guidance achievement faces execution risk given 71.0% revenue progress through Q3 and operating loss already exceeding full-year guidance, implying Q4 requires significant sequential improvement or guidance revision. Observable trends indicate segment-level profitability challenges persist across both Wellness and Financial Services, with IFA divestiture removing a loss-making operation but also reducing scale. Investors should monitor Q4 cost management actions, refinancing negotiations, and potential guidance updates as key indicators of stabilization trajectory versus continued deterioration.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.